Erschienen in:
20.06.2019 | Original Article
Tissue classification of oncologic esophageal resectates based on hyperspectral data
verfasst von:
Marianne Maktabi, Hannes Köhler, Margarita Ivanova, Boris Jansen-Winkeln, Jonathan Takoh, Stefan Niebisch, Sebastian M. Rabe, Thomas Neumuth, Ines Gockel, Claire Chalopin
Erschienen in:
International Journal of Computer Assisted Radiology and Surgery
|
Ausgabe 10/2019
Einloggen, um Zugang zu erhalten
Abstract
Purpose
Esophageal carcinoma is the eighth most common cancer worldwide. Esophageal resection with gastric pull-up is a potentially curative therapeutic option. After this procedure, the specimen is examined by the pathologist to confirm complete removal of the cancer. An intraoperative analysis of the resectate would be less time-consuming and therefore improve patient safety.
Methods
Hyperspectral imaging (HSI) is a relatively new modality, which has shown promising results for the detection of tumors. Automatic approaches could support the surgeon in the visualization of tumor margins. Therefore, we evaluated four supervised classification algorithms: random forest, support vector machines (SVM), multilayer perceptron, and k-nearest neighbors to differentiate malignant from healthy tissue based on HSI recordings of esophago-gastric resectates in 11 patients.
Results
The best performances were obtained with a cancerous tissue detection of 63% sensitivity and 69% specificity with the SVM. In a leave-one patient-out cross-validation, the classification showed larger performance differences according to the patient data used. In less than 1 s, data classification and visualization was shown.
Conclusion
In this work, we successfully tested several classification algorithms for the automatic detection of esophageal carcinoma in resected tissue. A larger data set and a combination of several methods would probably increase the performance. Moreover, the implementation of software tools for intraoperative tumor boundary visualization will further support the surgeon during oncologic operations.